Wondering how to use Aravive in a sentence? Below are 3 example sentences from authentic English texts. .
Aravive in a sentence
Context around Aravive
- Average sentence length in these examples: 22.7 words
- Position in the sentence: 1 start, 2 middle, 0 end
- Sentence types: 3 statements, 0 questions, 0 exclamations
Corpus analysis for Aravive
- In this selection, "aravive" usually appears in the middle of the sentence. The average example has 22.7 words, and this corpus slice is mostly made up of statements.
- Around the word, beats and stock stand out and add context to how "aravive" is used.
- Recognizable usage signals include aravive beats aerpio and shares of aravive stock in. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "aravive" sits close to words such as aaaaand, aaah and aacl, which helps place it inside the broader word index.
Example types with aravive
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Aravive beats Aerpio Pharmaceuticals on 7 of the 12 factors compared between the two stocks. (15 words)
Also, Director Srinivas Akkaraju acquired 133,333 shares of Aravive stock in a transaction that occurred on Monday, December 2nd. (20 words)
Among WuXi Biologics’ expanding ties in the U.S., the company in April said it would work with Aravive of Houston, a clinical-stage biopharmaceutical company, to develop antibodies for cancer and fibrosis. (33 words)
Among WuXi Biologics’ expanding ties in the U.S., the company in April said it would work with Aravive of Houston, a clinical-stage biopharmaceutical company, to develop antibodies for cancer and fibrosis. (33 words)
Also, Director Srinivas Akkaraju acquired 133,333 shares of Aravive stock in a transaction that occurred on Monday, December 2nd. (20 words)
Aravive beats Aerpio Pharmaceuticals on 7 of the 12 factors compared between the two stocks. (15 words)
Example sentences (3)
Among WuXi Biologics’ expanding ties in the U.S., the company in April said it would work with Aravive of Houston, a clinical-stage biopharmaceutical company, to develop antibodies for cancer and fibrosis.
Aravive beats Aerpio Pharmaceuticals on 7 of the 12 factors compared between the two stocks.
Also, Director Srinivas Akkaraju acquired 133,333 shares of Aravive stock in a transaction that occurred on Monday, December 2nd.